Sign inJoin waitlistJoin the waitlist

Pamela Soliman

Chair Ad Interim and Professor · University of Texas M D Anderson Cancer Center

Credentials: · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Internal Medicine
University of Texas Health Science Center at Houston
2019
Gynecologic Oncology
University of Texas M D Anderson Cancer Center
2003–2007
Obstetrics and Gynecology
Virginia Commonwealth University School of Medicine
1999–2003
Virginia Commonwealth University School of Medicine
1995–1999

Research

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
New England Journal of Medicine · 2006 · 560 citations
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 486 citations
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
Journal of the National Comprehensive Cancer Network · 2023 · 349 citations

Kathleen Schmeler
62 papers · 18 as a fellow
Michael Frumovitz
62 papers · 8 as a fellow
Pedro Ramirez
62 papers
Shannon Westin
61 papers · 2 as a fellow
Karen Lu
51 papers
Nicole Fleming
34 papers
AN
Alpa Nick
27 papers · 4 as a fellow
Larissa Meyer
26 papers · 1 as a fellow
Anil Sood
21 papers
RC
Robert Coleman
21 papers
Russell Broaddus
19 papers
Amir Jazaeri
17 papers

Grants

Training of Academic Gynecologic Oncologists
National Cancer Institute · T32
PI · $1.7M · University of Tx Md Anderson Can Ctr
2005–2031

Clinical trials

Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2023–2029
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
Principal investigator · Recruiting · Phase 1
M.D. Anderson Cancer Center
2023–2028
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2019–2028
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2017–2028